An official website of the United States government
CDC- BRFSS – ACBS 2022 Adult Prevalence Table 6
Updated September 20, 2024
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 327 | 29.4 | 4.3 | (21.0 – 37.8) |
| California | 305 | 31.9 | 4.3 | (23.5 – 40.3) |
| Connecticut | 491 | 30.5 | 3.1 | (24.4 – 36.6) |
| Florida | 454 | 34.1 | 4.7 | (24.9 – 43.3) |
| Georgia | 331 | 32.4 | 4.1 | (24.4 – 40.4) |
| Hawaii | 204 | 16.9 | 3.4 | (10.2 – 23.6) |
| Indiana | 476 | 33.3 | 2.9 | (27.6 – 39.0) |
| Iowa | 289 | 32.2 | 3.7 | (24.9 – 39.5) |
| Kansas | 230 | 36.1 | 5.1 | (26.1 – 46.1) |
| Maine | 355 | 34.4 | 3.9 | (26.8 – 42.0) |
| Maryland | 391 | 38.3 | 3.9 | (30.7 – 45.9) |
| Massachusetts | 333 | 33.2 | 3.6 | (26.1 – 40.3) |
| Michigan | 503 | 30.6 | 2.8 | (25.1 – 36.1) |
| Minnesota | 535 | 32.0 | 2.7 | (26.7 – 37.3) |
| Missouri | 237 | 32.3 | 4.6 | (23.3 – 41.3) |
| Nebraska | 159 | 26.1 | 4.7 | (16.9 – 35.3) |
| New Hampshire | 382 | 25.9 | 3.1 | (19.8 – 32.0) |
| New Jersey | 296 | 32.6 | 3.7 | (25.3 – 39.9) |
| New Mexico | 161 | 35.6 | 5.3 | (25.2 – 46.0) |
| New York | 317 | 26.4 | 3.3 | (19.9 – 32.9) |
| Ohio | 407 | 33.5 | 3.8 | (26.1 – 40.9) |
| Oregon | 137 | 39.4 | 5.5 | (28.6 – 50.2) |
| Rhode Island | 238 | 33.2 | 4.4 | (24.6 – 41.8) |
| Texas | 282 | 27.7 | 4.0 | (19.9 – 35.5) |
| Utah | 306 | 31.8 | 3.7 | (24.5 – 39.1) |
| Vermont | 501 | 30.3 | 2.7 | (25.0 – 35.6) |
| Wisconsin | 398 | 26.1 | 2.9 | (20.4 – 31.8) |
| Puerto Rico | 258 | 31.6 | 3.9 | (24.0 – 39.2) |
| 28 States / Area | 9,303 | 30.9 | 1.1 | (28.7 – 33.1) |
| Median | 32.1 | |||
| Range | 16.9-39.4 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2022/pdf/sdq_report_acbs_22-508.pdf